During the past decade, Neurological Associates of Long Island conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurological Associates of Long Island" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Avid Radiopharmaceuticals" with 1 trials sponsored, "IMS HEALTH GmbH & Co. OHG" with 1 trials sponsored, "Supernus Pharmaceuticals, Inc." with 1 trials sponsored and "Tetra Discovery Partners" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurological Associates of Long Island" #1 collaborator was "EMD Serono" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Neurological Associates of Long Island" are "Alzheimer Disease" (4 trials), "Alzheimer's Disease" (1 trials), "Cognition Disorders" (1 trials), "Idiopathic Parkinson Disease" (1 trials) and "Relapsing-remitting Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Neurological Associates of Long Island" in a lesser frequency.

Most popular intervention types in "Neurological Associates of Long Island" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Gantenerumab" (2 trials), "Azeliragon" (1 trials), "BPN14770" (1 trials) and "Rebif" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurological Associates of Long Island" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Neurological Associates of Long Island". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Neurological Associates of Long Island, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Neurological Associates of Long Island, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".